AYI Pharma Consulting Ltd 12507757 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is consultancy services to the pharmaceutical industry Digita Accounts Production Advanced 6.30.9574.0 true 12507757 2023-04-01 2024-03-31 12507757 2024-03-31 12507757 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 12507757 bus:Micro-entities 2023-04-01 2024-03-31 12507757 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12507757 bus:FilletedAccounts 2023-04-01 2024-03-31 12507757 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 12507757 bus:RegisteredOffice 2023-04-01 2024-03-31 12507757 bus:Director1 2023-04-01 2024-03-31 12507757 bus:Director2 2023-04-01 2024-03-31 12507757 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12507757 countries:EnglandWales 2023-04-01 2024-03-31 12507757 2022-04-01 2023-03-31 12507757 2023-03-31 12507757 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 12507757

AYI Pharma Consulting Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

AYI Pharma Consulting Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

AYI Pharma Consulting Ltd

Company Information

Directors

Dr A Young

Dr B W Young

Registered office

20 Beaulieu Gardens
West Bridgford
Nottingham
NG2 7TL

Accountants

Rafton Associates Ltd
8 Woodland Close
Markfield
Leicestershire
LE67 9QH

 

AYI Pharma Consulting Ltd

(Registration number: 12507757)
Balance Sheet as at 31 March 2024

2024
£

2023
£

Fixed assets

797

1,001

Current assets

80,234

41,917

Creditors: Amounts falling due within one year

(11,152)

(10,450)

Net current assets

69,082

31,467

Total assets less current liabilities

69,879

32,468

Accruals and deferred income

(865)

(765)

 

69,014

31,703

Capital and reserves

69,014

31,703

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
20 Beaulieu Gardens
West Bridgford
Nottingham
NG2 7TL

These financial statements were authorised for issue by the Board on 28 August 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

AYI Pharma Consulting Ltd

(Registration number: 12507757)
Balance Sheet as at 31 March 2024

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 August 2024 and signed on its behalf by:
 

.........................................
Dr A Young
Director